Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma

  1. Motzer, R.J.
  2. McDermott, D.F.
  3. Escudier, B.
  4. Burotto, M.
  5. Choueiri, T.K.
  6. Hammers, H.J.
  7. Barthélémy, P.
  8. Plimack, E.R.
  9. Porta, C.
  10. George, S.
  11. Powles, T.
  12. Donskov, F.
  13. Gurney, H.
  14. Kollmannsberger, C.K.
  15. Grimm, M.-O.
  16. Barrios, C.
  17. Tomita, Y.
  18. Castellano, D.
  19. Grünwald, V.
  20. Rini, B.I.
  21. McHenry, M.B.
  22. Lee, C.-W.
  23. McCarthy, J.
  24. Ejzykowicz, F.
  25. Tannir, N.M.
Revue:
Cancer

ISSN: 1097-0142,  0008-543X

Année de publication: 2022

Volumen: 128

Número: 11

Pages: 2085-2097

Type: Article

DOI: 10.1002/CNCR.34180 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus